Publicacións (69) Publicacións de MARIA DOLORES RAMONA TORRES LOPEZ

2021

  1. A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 524-545

  2. Correction to: A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin (Drug Delivery and Translational Research, (2021), 11, 2, (524-545), 10.1007/s13346-021-00920-x)

    Drug Delivery and Translational Research

  3. Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape

    Advanced Drug Delivery Reviews, Vol. 176

2019

  1. Intracellular delivery of an antibody targeting gasdermin-b reduces her2 breast cancer aggressiveness

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4846-4858

  2. Self-assembled hyaluronan nanocapsules for the intracellular delivery of anticancer drugs

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Influence of the surface properties of nanocapsules on their interaction with intestinal barriers

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 133, pp. 203-213

2017

  1. Advances on the formulation of proteins using nanotechnologies

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 155-180

  2. Modulating the immune system through nanotechnology

    Seminars in Immunology, Vol. 34, pp. 78-102

  3. Polyarginine Nanocapsules as a Potential Oral Peptide Delivery Carrier

    Journal of Pharmaceutical Sciences, Vol. 106, Núm. 2, pp. 611-618

  4. Polyarginine nanocapsules: A versatile nanocarrier with potential in transmucosal drug delivery

    International Journal of Pharmaceutics, Vol. 529, Núm. 1-2, pp. 474-485

2015

  1. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative

    International Journal of Pharmaceutics, Vol. 483, Núm. 1-2, pp. 212-219

2014

  1. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 87, Núm. 1, pp. 47-54

2013

  1. A new potential nano-oncological therapy based on polyamino acid nanocapsules

    Journal of Controlled Release, Vol. 169, Núm. 1-2, pp. 10-16

  2. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 330-337

  3. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery

    European Journal of Pharmaceutical Sciences, Vol. 49, Núm. 4, pp. 483-490

  4. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery

    International Journal of Pharmaceutics, Vol. 458, Núm. 1, pp. 83-89

  5. Intracellular delivery of docetaxel using freeze-dried polysaccharide nanocapsules

    Journal of Microencapsulation, Vol. 30, Núm. 2, pp. 181-188

  6. Poly-l-asparagine nanocapsules as anticancer drug delivery vehicles

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 85, Núm. 3 PART A, pp. 481-487

  7. Polyarginine nanocapsules: A new platform for intracellular drug delivery

    Journal of Nanoparticle Research, Vol. 15, Núm. 3

2012

  1. A potential nanomedicine consisting of heparin-Loaded Polysaccharide Nanocarriers for the Treatment of Asthma

    Macromolecular Bioscience, Vol. 12, Núm. 2, pp. 176-183